1. J.H. Weisburger, Comments on the history and importance of aromatic and heterocyclic amines in public health, Mutat. Res. 506–507 (2002) 9–20.
2. R.C. Garner, C.N. Martin, D.B. Clayson, Carcinogenic aromatic amines and related compounds, in: C.E. Searle (Ed.), Chemical Carcinogens, vol. 1, ACS Monograph 182, American Chemical Society, Washington, DC, 1984, pp. 175–213.
3. M.C. Yu, P.L. Skipper, S.R. Tannenbaum, K.K. Chan, R.K. Ross, Arylamine exposures and bladder cancer risk, Mutat. Res. 506–507 (2002) 21–28.
4. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene–environment interaction;Marcus;Cancer Epidemiol. Biomarkers Prev.,2000
5. T.V. Zenser, V.M. Lakshmi, F.F. Hsu, B.B. Davis, Metabolism of N-acetylbenzidine and initiation of bladder cancer, Mutat. Res. 506–507 (2002) 29–40.